Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating costs and expenses
General and administrative	$ 1,212	$ 1,303
Research and development	72	85
Research and development - license acquired	1,034	1,011
Total operating expenses	2,318	2,399
Loss from operations	(2,318)	(2,399)
Other income (expenses)
Other income	135
Interest income	27
Losses on marketable securities	(1,339)	(863)
Change in fair value of investment	(467)	(5,071)
Total other expenses	(1,644)	(5,934)
Net loss	$ (3,962)	$ (8,333)
Net loss per share, basic and diluted
Basic and Diluted (in Dollars per share)	$ (0.07)	$ (0.91)
Weighted average number of shares outstanding, basic and diluted
Basic and Diluted (in Shares)	60,281,906	9,195,594